Clinical trial
The Study of the Impact of Disclosing Imaging Study Information to Trial…
NCT00354003 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00354003 |
|---|---|
| Title | The Study of the Impact of Disclosing Imaging Study Information to Trial Participants |
| Official title | Impact of Disclosure of Dopamine Transporter Imaging Studies in PD Clinical Trials |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Parkinsonian Syndrome, Parkinson |
| Intervention type | Behavioral |
| Interventions | A series of questionnaires |
| Enrollment | 800 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 27, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jul 19, 2006 |
| Last update posted | Apr 3, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: